Adjuvant bisphosphonate treatment in early breast cancer: Meta-analyses of individual patient data from randomised trials.
Times cited: 264
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA).
British Journal of Cancer.
Times cited: 12